Search results
Results from the WOW.Com Content Network
Bipartisan bills introduced in Congress Thursday would effectively ban a Chinese genomics firm from doing business in America. Intel officials have warned China is grabbing U.S. genetic info.
Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. [ 1 ] The focus of the journal is biotechnology including research results and the commercial business sector of this field.
(Reuters) -The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with Chinese biotech companies like BGI and WuXi AppTec on national ...
The lawmakers' interest in GenScript comes two weeks after another committee in the House approved a bill that would restrict business with China's WuXi AppTec, WuXi Biologics BGI, MGI and ...
Nature ' s impact factor, a measure of how many citations a journal generates in other works, was 42.778 in 2019 (as measured by Thomson ISI). [1] [35] [36] However, as with many journals, most papers receive far fewer citations than the impact factor would indicate. [37] Nature's journal impact factor carries a long tail. [38]
However, as with nanotechnology and biotechnology, bionanotechnology does have many potential ethical issues associated with it. A ribosome is a biological machine. The most important objectives that are frequently found in nanobiology involve applying nanotools to relevant medical/biological problems and refining these applications.
Need help? Call us! 800-290-4726 Login / Join. Mail
Nature Biomedical Engineering is a monthly peer-reviewed scientific journal published by Nature Portfolio. [1] It was established in 2017. The editor-in-chief is Pep Pàmies.